logo

Allogene Therapeutics Inc (ALLO) Stock: The Story of a 52-Week Stock Range

TOST Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Allogene Therapeutics Inc’s current trading price is -39.11% away from its 52-week high, while its distance from the 52-week low is 88.12%. The stock’s price range during this period has varied between $2.23 and $6.89. The company, active in the Healthcare sector, saw a trading volume of around 3.03 million for the day, considerably higher average daily volume of 2.94 million observed over the last three months.

Allogene Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $6.89 on 05/15/23, while the lowest price during the same period was $2.23 on 12/01/23.

How Financial Performance Impacts Market Capitalization

Allogene Therapeutics Inc (ALLO) has experienced a quarterly rise of 54.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 709.33M and boasts a workforce of 361 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.49, with a change in price of +1.42. Similarly, Allogene Therapeutics Inc recorded 2,867,877 in trading volume during the last 100 days, posting a change of +50.90%.

How ALLO’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ALLO stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.18.

ALLO Stock Stochastic Average

As of today, the raw stochastic average of Allogene Therapeutics Inc over the last 50 days is at 50.08%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 0.32%. Further, the company’s Stochastic %K and %D values for the last 20 days were 15.10% and 26.10%, respectively.

ALLO Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 30.69%. However, over the past six months, we’ve seen a weaker performance of 7.84%. The price of ALLO leaped by -15.42% over the last 30 days. And in the last five days, it has fallen by -17.42%.